Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

ClinicalTrials.gov ID: NCT02109562

Public ClinicalTrials.gov record NCT02109562. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)

Study identification

NCT ID
NCT02109562
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Indivior Inc.
Industry
Enrollment
354 participants

Conditions and interventions

Conditions

Interventions

  • RBP-7000 Drug
  • Placebo Drug
  • Risperidone Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2014
Primary completion
Oct 31, 2014
Completion
Oct 31, 2014
Last update posted
Oct 25, 2018

2014

United States locations

U.S. sites
32
U.S. states
15
U.S. cities
28
Facility City State ZIP Site status
Woodland International Research Group, Inc. Little Rock Arkansas 72211
Woodland International Research Group, Inc. Springdale Arkansas 72764
Comprehensive Clinical Development - Cerritos, CA Cerritos California 90703
Synergy Clinical Research of Escondido Escondido California 92025
Behavioral Research Specialists, LLC Glendale California 91206
Collaborative Neuroscience Networks, Inc. Long Beach California 90806
Apostle Clinical Trials, Inc. Long Beach California 90813
Pacific Research Partners Oakland California 94612
Excell Research, Inc. Oceanside California 92056
CNRI- Los Angeles, LLC Pico Rivera California 90660
CNRI - San Diego, LLC San Diego California 92012
Innovative Clinical Research Fort Lauderdale Florida 33308
Behavioral Clinical Research, Inc. North Miami Florida 33021
Florida Clinical Research Center, LLC Orlando Florida 32751
Uptown Research Institute Chicago Illinois 60640
Alexian Brothers Behavioral Health Hospital Hoffman Estates Illinois 60169
Via Christi Research Wichita Kansas 67214
Lake Charles Clinical Trials, LLC Lake Charles Louisiana 70629
J. Gary Booker, MD, APMC Shreveport Louisiana 71104-2136
St. Louis Clinical Trials St Louis Missouri 63118
PsychCare Consultants Research St Louis Missouri 63128
Altea Research Institute Las Vegas Nevada 89102
CRI Lifetree Marlton New Jersey 08053
Neurobehavioral Research, Inc. Cedarhurst New York 11516
New Hope Clinical Research Charlotte North Carolina 28204
Midwest Clinical Research Center, LLC Dayton Ohio 45417
Oklahoma Clinical Research Center Oklahoma City Oklahoma 73112
CRI Lifetree Philadelphia Pennsylvania 19139
FutureSearch Clinical Trials, L.P. Austin Texas 78734
Community Clinical Research, Inc. Austin Texas 78754
FutureSearch Clinical Trials, L.P. Dallas Texas 75231
Pillar Clinic Research, LLC Dallas Texas 75243

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02109562, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2018 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02109562 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →